Latest Regulatory News

Peel Mining Limited reveals a robust high-grade resource base and ongoing exploration in the Cobar Basin, positioning itself for growth amid a dynamic regional mining landscape.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Energy Transition Minerals has appointed two former Danish diplomats to its Advisory Board, aiming to strengthen its rare earths project in Greenland amid ongoing legal challenges.

Artrya secures participation from Mass General Brigham, a leading U.S. cardiovascular research center, in its pivotal SAPPHIRE Study launching in early 2026. This collaboration aims to validate Artrya’s AI-powered Salix platform for earlier and more effective coronary artery disease detection.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

Kinetiko Energy has secured the first tranche of funding from FFS Refiners to accelerate development of a pilot LNG gas plant at Brakfontein, marking a key step in its multi-phase Project Alpha.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

KALiNA Power’s Canadian arm has completed a CAD$18 million transfer of allocated megawatts to Greenlight and its global data centre client, marking a significant milestone in its Alberta power projects.

Taiton Resources has secured regulatory approval to launch its first-ever drilling campaign at the Challenger West project in South Australia, targeting promising gold anomalies near a major existing mine.

QBE Insurance Group has priced a $300 million issue of USD subordinated notes due in 2037, offering investors a fixed 5.239% interest rate initially, with a reset in 2032 tied to U.S. Treasury yields. These notes strengthen QBE’s regulatory capital under APRA’s framework.

Far East Gold has secured a pivotal PIPPIB approval for 9,000 hectares of its Idenburg Gold Project in Papua, Indonesia, clearing a major regulatory hurdle and accelerating its path toward mine development.

Orthocell has appointed a second Canadian distributor for its nerve repair device Remplir™, achieving full national coverage and setting the stage for initial sales this quarter.